The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element

EMBO Journal

Volumn 17, Issue 21, 1998, Pages 6394-6403

  Aiyar, Ashok ^a   Tyree, Curtis ^a,b   Sugden, Bill ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b LIGAND PHARMACEUTICALS INC   (United States)

Author keywords

Cellular origin; EBNA 1; EBV; oriP; Plasmid eradication

Indexed keywords

CIS ACTING ELEMENT; TRANS ACTING FACTOR;

ARTICLE; CELL CYCLE; DNA REPLICATION ORIGIN; DNA SYNTHESIS; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; MITOSIS; NONHUMAN; PLASMID; PRIORITY JOURNAL; REPLICON; VIRUS DNA CELL DNA INTERACTION;

BROMODEOXYURIDINE; CELL LINE; DNA METHYLATION; DNA REPLICATION; DNA RESTRICTION ENZYMES; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; PLASMIDS; REPLICATION ORIGIN; REPLICON; TRANSCRIPTION, GENETIC; TRANSFECTION; VIRAL PROTEINS;

ANIMALIA; DNA VIRUSES; HUMAN HERPESVIRUS 4; MAMMALIA;

EID: 0032476591     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.21.6394     Document Type: Article

References (62)

1. Adams, A. (1987) Replication of latent Epstein-Barr virus genomes in Raji cells. J. Virol., 61. 1743-1746.
2. Aiyar, A. and Sugden, B. (1998) Fusions between EBNA-1 of EBV and the large T-antigen of SV40 replicate their cognate origins. J. Biol. Chem., in press.
3. Aiyar, A., Hindmarsh, P., Skalka, A.M. and Leis, J. (1996) Concerted integration of linear retrovirus DNA by avian sarcoma virus integrase in vitro: dependence on both long terminal repeat termini. J. Virol., 70, 3571-3580.
4. Ambinder, R.F., Shah, W.A., Rawlins, D.R., Hayward, G.S. and Hayward, S.D. (1990) Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA. J. Virol., 64, 2369-2379.
5. Ambinder, R.F., Mullen, M., Chang, Y.-N., Hayward, G.S. and Hayward, S.D. (1991) Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J. Virol., 65, 1466-1478.
6. Bacchetti, S. and Graham, F.L. (1977) Transfer of the gene for thydimine kinase to thymidine kinase-deficient human cells by purified herpes simplex viral DNA. Proc. Natl Acad. Sci, USA, 74, 1590-1594.
7. Baer, R. et al. (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature, 310, 207-211.
8. Biamonti, G., Della Valle, G., Talarico, D., Cobianchi, F., Riva, S. and Falaschi, A. (1985) Fate of exogenous recombinant plasmids introduced into mouse and human cells. Nucleic Acids Res., 13, 5545-5561.
9. Bochkarev, A., Barwell, J.A., Pfuetzner, R.A., Bochkareva, E., Frappier, L. and Edwards, A.M. (1996) Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin binding protein, EBNA-1, bound to DNA. Cell, 84, 791-800.
10. Bruckner, R.C., Crute, J.J., Dodson, M.S. and Lehman, J.R. (1991) The herpes simplex virus 1 origin binding protein: a DNA helicase. J. Biol. Chem., 266, 2669-2674.
11. Delecluse, H.J., Bartnizke, S., Hammerschmidt, W., Bullerdiek, J. and Bornkamm, G.W. (1993) Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt lymphoma cell lines. J. Virol., 67, 1292-1299.
12. DePamphilis, M.L. (1996) Origins of DNA replication. In DePamphilis, M.L. (ed.), DNA Replication in Eucaryotic Cells. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 45-86.
13. De Wet, J.R., Wood, K.V., DeLuca, M., Helsinki, D.R. and Subramani, S. (1987) Firefly luciferase gene: structure and function in mammalian cells. Mol. Cell. Biol., 7, 725-737.
14. Durfee, T., Becherer, K., Chen, P.L., Yeh, S.H., Yang, Y., Kilburn, A.E., Lee, W.H. and Elledge, S.J. (1993) The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev., 7, 555-569.
15. Frappier, L. and O'Donnell, M. (1991) Overproduction, purification and characterization of EBNA-1. the origin binding protein of Epstein-Barr virus. J. Biol. Chem., 266, 7819-7826.
16. Gahn, T.A. and Schildkraut, C.L. (1989) The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication. Cell, 58, 527-535.
17. Graham, F.L., Smiley, J., Russell, W.C. and Nairn, R. (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol., 36, 59-74.
18. Grogan, E.A., Summers, W.P., Dowling, S., Shedd, D., Gradoville, L. and Miller, G. (1983) Two Epstein-Barr viral nuclear neoantigens distinguished by gene transfer, serology and chromosome binding. Proc. Natl Acad. Sci. USA, 80, 7650-7653.
19. Harrison, S., Fisenne, K. and Hearing, J. (1994) Sequence requirements of the Epstein-Barr virus latent origin of DNA replication. J. Virol., 68 1913-1925.
20. Hearing, J., Mülhaupt, Y. and Harper, S. (1992) Interaction of Epstein-Barr virus nuclear antigen 1 with the viral latent origin of replication. J. Virol., 66, 694-705.
21. Hirt, B. (1967) Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol., 26, 365-3696.
22. Hsieh, D.J., Camiolo, S. and Yates, J.L. (1993) Constitutive binding of EBNA-1 protein to the Epstein-Barr virus replication origin, oriP, with distortion of DNA structure during latent infection. EMBO J., 12, 4933-4944.
23. Kirchmaier, A.L. and Sugden, B. (1995) Plasmid maintenance of derivatives of oriP of Epstein-Barr virus. J. Virol., 69, 1280-1283.
24. Kirchmaier, A.L. and Sugden, B. (1997) Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus. J. Virol., 71, 1766-1775.
25. *: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus. J. Virol., 72, 4657-4666.
26. Kirchmaier, A.L., Bloss, J.A., Mackey, D. and Sugden, B. (1995) Epstein-Barr viral plasmid vectors and their ampli fiable derivatives. In Adolph, K.W. (ed.), Viral Gene Techniques. Academic Press Inc., San Diego, pp. 65-86.
27. Knutson, J.C. and Yee, D. (1987) Electroporation: parameters affecting transfer of DNA into mammalian cells. Anal Biochem., 164, 44-52.
28. Krysan, P.J., Haase, S.B. and Calos, M.P. (1989) Isolation of human sequences that replicate autonomously in human cells. Mol. Cell. Biol., 9, 1026-1033.
29. Lacks, S.A. (1980) Purification and properties of the complementary endonucleases DpnI and DpnII. Methods Enzymol., 65, 138-146.
30. Laine, A. and Frappier, L. (1995) Identification of Epstein-Barr virus nuclear antigen 1 protein domains that direct interactions at a distance between DNA-bound protein. J. Biol. Chem., 270, 30914-30918.
31. Lehman, C.W. and Botchan, M.R. (1998) Segregation of viral plasmids depends on tethering to chromosomes and is regulated by phosphorylation. Proc. Natl Acad. Sci. USA, 95, 4338-4343.
32. Li, J.J. and Herskowitz, I. (1993) Isolation of ORC6, a component of the yeast origin recognition complex by a one-hybrid system. Science, 262, 1870-1874.
33. Lupton, S. and Levine, A.J. (1985) Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus derived plasmids in human cells. Mol. Cell. Biol., 5, 2533-2542.
34. Mackey, D. and Sugden, B. (1997) Studies on the mechanism of DNA linking by Epstein-Barr virus nuclear antigen 1. J. Biol. Chem., 272, 29873-29879.
35. Mackey, D., Middleton, T. and Sugden, B. (1995) Multiple regions within EBNA-1 can link DNAs. J. Virol., 69, 6199-6208.
36. Marahrens, Y. and Stillman, B. (1992) A yeast chromosomal origin of DNA replication defined by multiple functional elements. Science, 255, 817-823.
37. Masukata, H., Satoh, H., Obuse, C. and Okazaki, T. (1993) Autonomous replication of chromosomal DNA fragments in human cells. Mol. Biol. Cell, 4, 1121-1132.
38. Meuth, M. and Green, H. (1974) Induction of a deoxycytidineless state in cultured mammalian cells by bromodeoxyuridine. Cell, 2, 104-112.
39. Middleton, T. and Sugden, B. (1992) EBNA-1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication. J. Virol., 66, 489-495.
40. Middleton, T. and Sugden, B. (1994) Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1. J. Virol., 68, 4067-4071.
41. Piirsoo, M., Ustav, E., Mandel, T., Stenlund, A. and Ustav, M. (1996) Of and trans requirements for stable episomal maintenance of the BPV-1 replicator. EMBO J., 15, 1-11.
42. Rawlins, D.R., Milman, G., Hayward, S.D. and Hayward, G.S. (1985) Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 42, 859-868.
43. Reisman, D., Yates, J. and Sugden, B. (1985) A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol. Cell. Biol., 5, 1822-1832.
44. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
45. Sandberg, M., Hammerschmidt, W. and Sugden, B. ( 1997) Characterization of LMP-l's association with TRAF1, TRAF2 and TRAF3. J. Virol., 71, 4649-4656.
46. Schleiss, M.R., Degnin, C.R. and Geballe, A.P. (1991) Translational control of human cytomegalovirus gp48 expression. J. Virol., 65, 6782-6789.
47. Shimizu, N., Itoh, N., Utiyama, H. and Wahl, G.M. (1998) Selective entrapment of extrachromosomally amplified DNA by nuclear budding and micronucleation during S phase. J. Cell. Biol., 140, 1307-1320.
48. Simpson, K., McGuigan, A. and Huxley, C. (1996) Stable episomal maintenance of yeast artificial chromosomes in human cells. Mol. Cell. Biol., 16, 5117-5126.
49. Simpson, R.T. (1990) Nucleosome positioning can affect the function of a cis-acting DNA element in vivo. Nature, 343, 387-389.
50. Stahl, H., Droge, P. and Knippers, R. (1986) DNA helicase activity of SV40 large tumor antigen. EMBO J., 5, 1939-1944.
51. Sugden, B andWarren, N. (1988) Plasmid origin of replication of Epstein-Barr virus, oriP, does not limit replication in cis. Mol. Biol. Med., 5, 85-94.
52. Thompson, J.F., Hayes, L.S. and Lloyd, D.B. (1991) Modulation of firefly luciferase stability and impact on studies of gene regulation. Gene, 103, 171-177.
53. Veit, J.E. and Hangman, W.L. (1988) Copy number and partition of the Saccharomyces cerevisiae 2 micron plasmid controlled by transcription regulators. Mol. Cell. Biol., 8, 4949-4957.
54. Von Hoff, D.D., McGill, J.R., Forseth, B.J., Davidson, K.K., Bradley, T.P., Van Devanter, D.R. and Wahl, G.M. (1992) Elimination of extrachromosomally amplified MYC genes from human tumor reduces their tumorigenicity. Proc. Natl Acad. Sci. USA. 89, 8165-8169.
55. Wen, L.-T., Lai, P.K., Bradley, G., Tanaka, A. and Nonoyama, M. (1990) Interaction of the Epstein-Barr viral (EBV) origin of replication (oriP) with EBNA-1 and cellular anti-EBNA-1 proteins. Virology, 178, 293-296.
56. Wu, L.C., Fisher, P.A. and Broach, J.R. (1987) A yeast plasmid partitioning protein is a karyoskeletal component. J. Biol. Chem., 262, 883-891.
57. Wysokenski, D.A. and Yates, J.L. (1989) Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. J. Virol., 63, 2657-2666.
58. Yang, L., Mohr, I., Fouts, E., Lim, D.A., Nohaile, M. and Botchan, M. (1993) The E1 protein of bovine papilloma virus 1 is an ATP-dependent DNA helicase. Proc. Natl Acad. Sci. USA, 90, 5086-5090.
59. Yates, J.L. and Guan, N. (1991) Epstein-Barr virus-derived plasmids replicate only once per cell-cycle and are not amplified after entry into cells. J. Virol., 65, 483-488.
60. Yates, J., Warren, N., Reisman, D. and Sugden, B. (1984) A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl Acad. Sci, USA, 81, 3806-3810.
61. Yates, J.L., Warren, N. and Sugden, B. (1985) Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature, 313, 812-815.
62. Yee, C., Krishnan-Hewlett, I., Baker, C.C., Schlegel, R. and Howley, P.M. (1985) Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am. J. Pathol., 119, 361-366.